Abstract
The objective was to identify factors associated with decisions made by patients with amyotrophic lateral sclerosis (ALS) to accept or decline non-invasive ventilation (NIV) and/or gastrostomy in a prospective population-based study. Twenty-one people with ALS, recruited from the South-East ALS Register who made an intervention decision during the study timeframe underwent a face-to-face in-depth interview, with or without their informal caregiver present. Sixteen had accepted an intervention (11 accepted gastrostomy, four accepted NIV and one accepted both interventions). Five patients had declined gastrostomy. Thematic analysis revealed three main themes: (1) patient-centric factors (including perceptions of control, acceptance and need, and aspects of fear); (2) external factors (including roles played by healthcare professionals, family, and information provision); and (3) the concept of time (including living in the moment and the notion of ‘right thing, right time’). Many aspects of these factors were inter-related. Decision-making processes for the patients were found to be complex and multifaceted and reinforce arguments for individualised (rather than ‘algorithm-based’) approaches to facilitating decision-making by people with ALS who require palliative interventions.
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.Avoid common mistakes on your manuscript.
Introduction
Amyotrophic lateral sclerosis (ALS) is an incurable neurological disease characterised by progressive multisystem degeneration, with an average survival of 2–5 years after diagnosis [1–3]. Current interventions are limited to slowing disease progression or palliating symptoms such as dysphagia, weight loss, and respiratory muscle weakness [3, 4] and the recommended interventions, such as gastrostomy and non-invasive ventilation (NIV), tend to be required by people with ALS (pwALS) in later stages of the disease [3, 5]. Gastrostomy has been shown to improve nutrition, and NIV can help relieve the symptoms experienced due to diaphragmatic weakness, interventions which have improved prognosis and quality of life [6–9] without increasing caregiver burden [7]. Rates of uptake for NIV in the UK may currently be low [10]. While rates of acceptance of gastrostomy are not available for the UK, rates in the USA range from 0 to 63 % [9]. Evidence-based guidelines based largely on expert opinion recommend the use of NIV in ALS [11–14]. Findings [15] confirm observations from non-randomised trials and emphasise that NIV is part of ‘best management’ for people with ALS (pwALS).
The process of decision-making deserves exploration [16]. In quantitative studies, factors found to affect decision-making by pwALS in terms of NIV (and ventilation more generally) and gastrostomy include disease characteristics such as severity of symptoms [17]; demographic factors such as gender, age, educational level and IQ; and various psychological characteristics such as health beliefs, understanding of the illness, attachment to life, religiosity and mood (see [17–23] ) as well as carer-rated everyday behavioural change indicative of executive dysfunction [17]. It has also been found that pwALS who indicate possible acceptance of NIV and gastrostomy early on in the disease trajectory are more likely to abide by their initial decision [24, 25]. In addition, acceptance of gastrostomy is related to a lack of pleasure obtained from oral intake and the inability to eat independently [26]. In a broader context, prospective research has demonstrated significant burden and psychological distress in caregivers of pwALS [7, 27, 28], but the relationship with palliative interventions has not always been explored [27].
Few qualitative studies have examined decision-making in ALS [29–31]. Research has elicited possible influences (including input from family and friends; religious and moral convictions and life sustenance [29]) and has identified themes such as the meaning of the intervention, the importance of context and values, the effect of fear, the need for information, and adaptation to or acceptance of the intervention [30]. Other influential factors were determined to be structural, interactional and personal [31]. It has been concluded [31] that decision-making is strengthened when patients experience co-operative relationships with healthcare professionals (HCPs) which support their personal beliefs. However, the findings are limited due to small sample sizes [29] and research has not specifically focused on gastrostomy and NIV [31, 32].
HCPs require sufficient knowledge to contribute effectively to decision-making [33] but there is mixed-quality evidence that non-ALS specialist HCPs lack knowledge of the disease [14]. Additionally, HCPs may have differing approaches to existing guidelines and conflicting opinions regarding the appropriate timing of an intervention [34] and discussions concerning NIV and gastrostomy are often initiated too late with little time for patients to discuss their preferences or for decisions to be unhurried [35, 36]. Nonetheless, the provision of information by HCPs has been found to be instrumental in patients’ treatment decisions [37, 38].
Therefore, research exploring decision-making regarding interventions in ALS is mostly lacking. The qualitative studies that exist used semi-structured interviews or questionnaires [16, 39, 40] or investigated an a priori list of potential influencing factors [26]). However, they all provide limited understanding of the direct experience of pwALS in their specific decision-making process. The aim of the present prospective study was to identify from the perspective of pwALS other factors that influence decision-making, to understand better the processes involved in accepting or declining NIV and/or gastrostomy in ALS.
Materials and methods
Participants
PwALS were recruited from the South-East ALS register [41] as part of a larger, prospective study of decision-making about gastrostomy and NIV in ALS [17]. Inclusion criteria for this qualitative study were: confirmed diagnosis of ALS; duration of disease at entry into the larger study [17] between 6 and 60 months; and referral for NIV and/or gastrostomy, with a decision to either accept or decline the intervention. PwALS were not excluded on the basis of clinically apparent cognitive impairment, provided they could give valid informed consent. However, a detailed formal neuropsychological assessment of participants was not undertaken due to the number of measures administered in the larger study [17]; we had wanted to limit the burden on participants, both at entry to the study and following an intervention decision. At the latter time-point, patients’ increasing ill-health may, in any case, have made it less likely that a lengthy neuropsychological assessment would have been acceptable to them.
Following an intervention decision, patients and their caregivers were invited to participate in a post-decision assessment including an in-depth interview. For those agreeing to an intervention, the assessment occurred after gastrostomy placement or NIV trial. For those refusing an intervention, interviews were arranged as soon as possible after decision confirmation.
Ethics
Ethical approval was granted by the Joint South London and Maudsley and the Institute of Psychiatry NHS Research Ethics Committee (LREC 07/H0807/87). Written informed consent was obtained from all participants. The study was, therefore, performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.
Data collection
Semi-structured interviews were conducted by two experienced researchers (either by NHM—a clinical psychologist- or AJ, a post-doctoral researcher) in patients’ homes and lasted 40–60 min. Those with speech difficulties used communication aids (e.g. a litewriter) or their carers spoke on their behalf. The interview schedule asked participants why they accepted/refused the intervention; their understanding of the intervention offered; their concerns related to interventions; their experiences leading up to making the decision including surrounding support and how the choice was offered. Open-ended questions were generated from a review of the literature and in consultation with experts in the clinical management of pwALS and palliative care. The interview guide was amended iteratively and aimed to follow the priorities and concerns raised by participants.
Analysis
Interviews were digitally recorded and transcribed verbatim. All identifying data were anonymized. An inductive thematic analysis approach [42] was adopted and data analysis software NVivo 9 (QSR International Version 9, 2010) was used to collate and manage the data. Initial transcripts were read repeatedly to enable the researcher (LPG) to become familiar with the data and identify preliminary patterns and themes. Data were divided into meaningful chunks and coded and the emergent themes were then examined for areas of convergence and divergence and grouped into higher level related concepts. A coding structure was devised and the ensuing framework was used as a basis for the remaining analysis. As new themes emerged in the residual data, the structure changed to incorporate developments and through this process of distillation, the main themes were produced. The superordinate themes were clustered within the main themes. The coding framework was regularly reviewed and refined through discussion between the research team (LPG, NHM, VL and LHG).
Results
Participants
From our larger sample of 78 people with ALS [17], a total of 32 people (41 %) made at least one intervention decision. Of these, 10 decided about both interventions. Our current sample comprised 21 people who agreed to and were well enough to participate in a post-decision interview (see Table 1). None of the 21 participants interviewed had declined NIV. Twelve participants were interviewed with their carers (these carers are denoted by ‘B’ in the tables) and a proportion of them communicated via a litewriter. One participant made two decisions and he and his carer (39A/B) were interviewed about each on separate occasions.
Themes
Three superordinate themes emerged from the data that related to the decision-making process. These themes were: (1) patient-centric factors, which were directly related to the personal experience of the patient; (2) external factors, defined as influencing factors independent of the participant, namely the HCPs; his/her family and the issues surrounding information provision; and (3) the concept of time—the different aspects of time and their effects on the patient and his/her decision-making abilities.
Of those interviewed, 16 agreed to the intervention and five declined. Data analysis aimed to explore similarities and differences in themes across these two groups.
Patient-centric factors (see Table 2)
Patient-centric factors emerged as influential in the decision-making process. These incorporated ‘perceptions of choice and control’, ‘acceptance and need’, and ‘aspects of fear’.
Perceptions of choice and control
Taking control: The majority of participants took an active role in deciding whether or not to have an intervention. Whilst they could not control the diagnosis of a life-limiting disease, they wished to manage their lives and take active responsibility for themselves and their choices (see Table 2: 1 and 2), something participants commonly felt resided with them alone. Several pwALS appeared to be able to face up to the prospect of their own death (e.g., Table 2: 3). Remaining in control of one’s body and not being swayed by others was also a strong theme (Table 2: 4).
Absence of choice: This theme was more prominent in the group who accepted an intervention because many viewed the intervention as an unavoidable consequence of ALS (Table 2: 5 and 6). Some participants expressed being unable to actively make a decision—the progression of the disease necessitated an intervention for them to continue living.
Acceptance and need
Acceptance: The acceptance of the condition and its subsequent progression emerged as a prominent theme among those accepting the intervention, with this also relating to participants’ acceptance of help. The decision was made because they wished to survive as long as possible and there would be a need for an intervention at some point along the disease’s trajectory (Table 2: 7 and 8). Continuing deterioration was a trigger for some people that heightened their awareness of what the disease path was likely to be, and the impact of this on the patient was paramount in the decision-making process (Table 2: 9).
Physical need for intervention: This sub-theme was apparent largely in those who accepted an intervention. Reaching a physical stage (and being faced with clear symptoms) when participants believed there was no other choice, made the decision to accept the intervention more straightforward (Table 2: 10 and 11).
Non-acceptance: Some participants were forthright about their fear of the future. They were more focused on living in the present and only confronted issues when there was an obvious need (Table 2: 12). This meant that the ability to make a decision based on what could occur in the future was curtailed; they were in a state of active denial or non-acceptance (Table 2: 13). However, this did not seem to have an impact upon the final decision taken.
Aspects of fear
Fear of the procedure: The fear of the intervention itself was an immediate threat to some people and this influenced their treatment decision (Table 2: 14 and 15). Some had been advised to have a gastrostomy ‘sooner rather than later’, yet while they were still able to breathe or swallow/eat they found it difficult to view the intervention as necessary. Therefore, fear around the required operation was prominent whereas the timing of likely physical decline was unknown. There appeared, therefore, to be a direct relationship between fear of the intervention and it being declined.
Prior health experience: Some participants’ decisions were coloured by a previous unpleasant health experience, either experienced personally or by someone close to them. This seemed to produce a strong fear response based around the prospect of repeating the upsetting event (Table 2: 16 and 17).
External factors (see Table 3)
The external factors that influenced acceptance or refusal of an intervention related to ‘healthcare professionals’ (HCPs); ‘family’ and ‘information’.
HCPs: Doctors, nurses, therapists, care workers
Supportive and supporting behaviours: Decisions to have the interventions were taken with the support of HCPs and participants’ families. However, ultimately the decision lay with the patient. Some participants experienced their HCPs as being very supportive and caring, and were thankful that HCPs showed humanity and provided reassurance (Table 3: 1 and 2, respectively).
Guidance: Certain HCPs guided their patients into having an intervention (making ‘the right decision’) (Table 3: 3). Some informed patients about the consequences of leaving the intervention too late and were keen for their patient to have the procedure (Table 3: 4 and 5).
Trust/lack of trust in the expert: Directly related to ‘Guidance’, patients perceived that HCPs used their expertise to encourage acceptance of the intervention. Participants needed to feel they could trust their HCPs; some spoke about having no choice, as well as seeing the HCPs as needing to shoulder some of the responsibility (Table 3: 6). Participants also took HCPs’ expertise seriously (Table 3: 7). Conversely, some were concerned by their apparent lack of knowledge about ALS (Table 3: 8) and felt under-supported in making a suitable decision.
Decision pressure from HCPs: Some participants felt pressurised by HCPs into making a decision (Table 3: 8 and 9), and experienced the frequent expression of the necessity of having an intervention as unpleasant (Table 3: 10). This highlighted tension around who was ultimately responsible for making the decision and who had enough information to ‘know’ what was the ‘right thing’. Relevant here is the case of 20A (Table 3: 11), who fought pressure from HCPs to retain his own control. However, he eventually decided to have the procedure.
Family
As a source of support: Those pwALS who had support from their families appeared marginally more likely to agree to the intervention. Having supportive families played a major role in participants’ ability to make a decision, feeling that the burden of the decision was shared (Table 3: 12).
As emotional pressure: Some patients experienced their families more negatively, with the family members’ emotional needs taking precedence over those of the patient (Table 3: 13). Some decisions to accept an intervention evolved out of concerns for family members and not the participant’s direct wishes (Table 3: 14).
Information
Provision of information: There was variability in how patients accessed information. Some sought to have this provided by HCPs and it was only in retrospect that they realised the paucity of what they had been told (Table 3: 15 and 16). However, others found that they were provided with enough information from various sources (Table 3: 17 and 18). Making the decision seemed to be easier for those who wished for and had access to different sources of information.
Amount of information: There was a small contingent who felt that they had been supplied with plenty of information and this, in turn, gave them confidence in making their decision [Table 3: 19).
Actively seeking information: Some participants took an active role in finding information; this bears direct relation to perceptions of control and responsibility. They sought advice to determine the best course of action. Those who decided against an intervention were more likely to actively seek answers to their questions (Table 3: 20).
Accuracy of information: An apparent lack of accuracy in the information offered to many participants caused consternation and disrupted the decision-making process (Table 3: 21). Participants reported a lack of consistency in information in relation to the disease and, in retrospect, what they should expect from the intervention (Table 3: 22 and 23). Some participants were less able to make a considered decision because they were unclear about aspects of the intervention (Table 3: 24).
Individualised Information: There was a clear need for information to be individualised. Each person had varying requirements and abilities and this added to the complexity of decision-making (Table 3: 25 and 26). According to his carer (34B), 34A (Table 3: 27) used his ability to reflect and analyse the information and choices available to challenge the HCPs, with this relating back to the themes of perception of control.
The concept of time (Table 4)
The concept of time was influential for the decision-making process and consisted of ‘living in the moment’; ‘right thing, right time’ and ‘predicting the future’.
Living in the moment
Some participants managed their situations by focusing on issues occurring in the present, their decisions emanating from that viewpoint (Table 4: 1), rather than worrying about the future (Table 4: 2). Some decided not have the intervention but were aware that as things changed, they might revisit that decision (Table 4: 3) signifying a fluidity within the decision-making process.
‘Right thing, right time’
The idea of there being a ‘right’ moment for the ‘right’ decision was evident (Table 4: 4). Several participants had been advised to have the intervention whilst they were still physically strong enough to undergo the procedure but chose not to have the intervention then. However, due to the inherent variability in disease progression, it was difficult for patients to know how, and when, to make a decision, as this would only be clear in retrospect (Table 4: 5). Not being able to predict the course of the disease made decision-making complicated (Table 4: 6 and 7). Decisions had to be made based on what was happening at the time, as well as what could happen in the future (Table 4: 8). Comments by 37B (Table 4: 9) question the language that HCPs used to assist patients in making decisions—using for example a ‘stock phrase’ (e.g. “sooner rather than later”) was perceived as unhelpful to patients, as it highlighted a lack of knowledge of their likely disease trajectory.
Discussion
This study investigated the factors involved in decision-making regarding acceptance or refusal specifically of NIV and/or gastrostomy for pwALS in a prospective UK sample drawn from a population register. Relative to recent qualitative studies [e.g., 31], the sample was large and all participants took part in face-to-face interviews. Three main themes emerged from the analysis: (1) patient-centric factors which included perceptions of control, acceptance and need, and aspects of fear; (2) external factors which included the roles played by healthcare professionals, family, and information; and (3) the concept of time, including living in the moment, and the notion of ‘right thing, right time’. Many of these factors were inter-related and decision-making processes for pwALS were found to be complex, multifaceted and individual. The patient-centric factors had the most immediate and direct relationship with the decision-making process, followed by external factors (wherein the support or lack thereof and the pressure to make a decision from the HCPs and family members had varying impacts); here, the amount and quality of information given or sought were also important. Our findings highlight that while pwALS are respectful of HCPs’ expertise and knowledge, they recognise when HCPs are less well informed about interventions and this may have a negative impact on patients’ experience of decision-making. Finally, the concept of time served as an underlying influence.
Our UK-based findings are largely in line with previous studies (both quantitative and qualitative) on decision-making in ALS [e.g. 17–23, 29–31]. As elsewhere [31], the relationship between pwALS and their HCPs was important in decision-making, and the support, or lack thereof, offered by HCPs had a direct impact on whether or not an intervention was accepted. There was a clear discrepancy between pwALS whose priorities were more focused on their current situation, as discussed elsewhere [31], and HCPs’ ‘best practice’ suggestions of interventions to counter future difficulties related to the progressive nature of the disease. This ‘worst-case’ decision-making context [31] was experienced by some pwALS as pressure, which added to their distress. It is possible that during the course of this study such pressure may have increased due to the publication of UK guidelines regarding NIV provision [14], which may have resulted in an increase in the number of pwALS being offered NIV. In contrast, other pwALS felt supported and understood by their HCPs.
The role of informal carers in decision-making by pwALS has been interpreted as enhancing ALS patient-centred care [31] by contributing to a patient–carer–HCP decision-making triad; the challenges of this relationship were not fully explored in the current study. Nonetheless, our findings suggest that while supportive carers may facilitate acceptance of interventions, they may also contribute to pressure on pwALS to opt for an intervention counter to their own preferences. Elsewhere, it has been suggested that it may be important for pwALS that their families accept their care-related decisions [32], while those with no immediate family may feel less constrained in the decisions they make.
Another important factor in the decision-making process was whether pwALS perceived that control over their illness resided with them or with HCPs and the interventions they could provide. Those who felt they had no choice but to accept an intervention considered the disease was dictating the need; they appeared to have an external health locus of control (i.e., they believe they or others have the ability to control their health status) in contrast to those who wished to maintain control over the disease itself and not rely on external interventions. Evidence of physical deterioration signalled a need for an intervention to sustain life; this was a strong factor influencing acceptance of an intervention and was consistent with previous studies [19, 26]. Our findings, as elsewhere [32], also indicated that pwALS’ prior medical experiences might need to be explored and understood when advice is given about interventions.
The theme ‘the concept of time’ was complex and, from the perspective of pwALS, was experienced differently by them and their HCPs. For the pwALS, ‘time’ was experienced as something relating either to the present or the past. There was a sense that pwALS here, as in other studies [31] were choosing to focus on the immediate and ‘known’, and not to contemplate the future. This may have been due to their inability to determine the specific future trajectory of the disease as well as being in a state of denial or non-acceptance, and electing to focus attention on aspects of their condition over which they felt they currently had some control. In contrast, pwALS felt that the HCPs who tended to view time as ‘lacking’ placed pressure on pwALS to have an intervention. In reality, the unpredictable nature of the disease course means that there may need to be a cyclical pattern of decision-making as symptoms change [43] and life-stage transitions may also determine the decisions likely to be made [32]. This finding may help HCPs to develop more patient-focused ways of supporting and advising pwALS.
Current findings concur with results from a quantitative study on the same participants [17], where those people who were more active in their information-seeking were more likely to refuse an intervention. This may be related to specific individual characteristics and coping styles but it is clear that receipt of more information did not necessarily result in acceptance of an intervention. This may be due to greater understanding of the implications or side effects of an intervention, resulting in pwALS deciding to retain the ‘status quo’. Our related study [17] also found that those with less understanding of their illness were also more likely to refuse an intervention. This may be related to fear or misguided perceptions about the intervention or could more generally reflect a lack of, or poor quality, information. Certainly, those who were specifically concerned about having the procedure were more likely to decline an intervention, suggesting a relationship between information-seeking behaviours, quality and accuracy of information sought or offered and understanding.
Interestingly, our current study did not reveal any evidence for influences of spiritual determinants or religiosity on decision-making that have been found in other papers [23, 29] and echoes other findings [31]. However, the role of religiosity/spirituality in decision-making was not specifically asked about and this could be seen as a limitation: religiosity (found elsewhere to maintain quality of life in pwALS [44]) may be something that is only discussed once prompted. In our related quantitative study where pwALS were specifically asked about religiosity, lower levels of religiosity were more likely to be associated with intervention refusal [17].
As noted earlier, participants did not undergo formal detailed neuropsychological testing in this study, nor did we explore the role of cognitive involvement [45] in decision-making in our interviews. Of relevance, however, is that our related quantitative study [17] indicated that the presence of everyday executive dysfunction in patients (as rated by caregivers) at study entry and ratings of pre-illness executive dysfunction and disinhibition were likely to be associated with the subsequent refusal of an intervention. That study [17] questioned whether more impaired patients might be less able to evaluate information about interventions and indeed whether they are in some implicit way discouraged from undergoing interventions, through concern over compliance in cognitively impaired patients [46]. Our wider findings [17] resonate with other work suggesting that cognitive impairment might potentially reduce patients’ involvement in decision-making [31], and might argue for at least routine screening (if not full neuropsychological assessment) of cognitive and behavioural change [e.g., 47] when considering patients’ ability to engage in decision-making.
Implications
Importantly, those who had declined interventions felt they had the choice—at a later stage in the disease’s trajectory—to rescind their decision. There seems to be a pattern of cyclic revisiting as the situation for pwALS is one of change [43]. This study captured the decision-making process at the point at which a decision was made. However, pwALS may well have been considering options for interventions over a longer period of time and more enduring psychological and emotional characteristics may be explanatory factors [17]. Whilst there is a definite moment at which a decision is communicated it can take variable lengths of time for the person to reach that point. Carers and HCPs need to be attuned to the dynamic nature of this process.
This paper highlights the need to offer pwALS individualised support to aid decision-making. For example, being able to recognise those who have an ‘active’ approach as opposed to those who are more passive (in such things as information-seeking) and developing individualised support may be beneficial to patients’ decision-making. Simply responding to treatment guidelines may lead to pwALS perceiving themselves as being pressurised. Conversely, recognising that those who took a more active approach to information-seeking were ultimately more likely to refuse an intervention should not result in HCPs being less willing to address patients’ concerns about an intervention.
Those pwALS who believe that the choice to accept or decline intervention is ultimately theirs appear to respond differently from those who feel that the control is external to them and that they are being controlled by the disease and supported (or not supported) by the HCPs responsible for their care. It may be difficult for an HCP to gauge the correct level and depth of information for their patient, depending on the patient’s health locus of control. Offering clear information on quality of life and symptomology post-intervention, as well as taking into account levels of fear, may go some way to ease the decision-making process.
Limitations
As with all qualitative methodology, this study’s findings may only generalise to the population from which this sample was drawn, and only represent the specific questions asked in the interviews. However, the involvement of pwALS drawn from a population register may overcome some potential limitations of clinic-based studies.
Due to communication difficulties, as in other studies (e.g. [32]), some pwALS’ carers spoke on their behalf; hence whilst the views may well have been those of the pwALS, they would have been shared through the filter of the carer. However, we considered it more important not to exclude pwALS with communication difficulties.
In this study, only five pwALS were interviewed who had declined gastrostomy and thus reasons for refusal could not be explored as thoroughly. Alternatively, this could indicate that proportionately more pwALS opt to accept this intervention rather than decline. In a similar way, there was a lack of interviews for those who declined NIV. This, however, may be due to the fact that NIV is usually required during the later disease stages [3]; hence, pwALS are generally more unwell at this point. In this study, those who declined NIV died soon after making their decision [17].
In conclusion, this study suggests that decision-making for intervention in terms of NIV or gastrostomy in ALS is a complex, unpredictable and fluid process, influenced by relationships with HCPs, with family and related to the concept of time. The discrepancy between pwALS’ autonomy and HCPs’ guidance towards intervention (experienced by some as pressure) demonstrates the need for individualised treatment and for more patient-focused support.
References
Lee JR, Annegers JF, Appel SH (1995) Prognosis of amyotrophic lateral sclerosis and the effect of referral selection. J Neurol Sci 132:207–215
Al-Chalabi A, Hardiman O (2013) The epidemiology of ALS: a conspiracy of genes, environment and time. Nat Rev Neurol. 9:617–628. doi:10.1038/nrneurol.2013.203 (Epub 2013 Oct 15)
Roche JC, Rojas-Garcia R, Scott KM et al (2012) A proposed staging system for amyotrophic lateral sclerosis. Brain 135:847–852
Tandon R, Bradley WG (1985) Amyotrophic lateral sclerosis: part 1. clinical features, pathology, and ethical issues in managements. Ann Neurol 18:271–280
Andersen PM, Abrahams S, Borasio GD et al (2012) EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)—revised report of an EFNS task force. Eur J Neurol 19:360–375
Bach JR (2012) Amyotrophic lateral sclerosis: prolongation of life by non invasive respiratory AIDS. Chest 122:92–98
Mustfa N, Walsh E, Brant V, Lyall RA, Addington-Hall J, Goldstein LH et al (2006) The effect of non-invasive ventilation on ALS patients and their caregivers. Neurology 66:1211–1217
Mazzini L, Corra T, Zaccala M, Mora G, Del Piano M, Galante M (1995) Percutaneous endoscopic gastrostomy and enteral nutrition in amyotrophic lateral sclerosis. J Neurol 242:695–698
Mitsumoto H, Davison M, Moore D, Gad N, Brandis M, Ringel S et al (2003) Percutaneous endoscopic gastrostomy (PEG) in patients with ALS and bulbar dysfunction. Amytroph Lateral Scler Other Motor Neuron Disord 4:177–185
Bourke SC, Williams TL, Bullock RE, Gibson GJ, Shaw PJ (2002) Non-invasive ventilation in motor neuron disease: current UK practice. Amyotroph Lateral Scler 3:145–149
Andersen PM, Borasio GD, Dengler R, Hardiman O, Kollewe K, Leigh PN, Pradat PF, Silani V, Tomik B (2005) EFNS task force on management of amyotrophic lateral sclerosis: guidelines for diagnosing and clinical care of patients and relatives. An evidence-based review with good practice points. Eur J Neurology 12:921–938
Heffernan C, Jenkinson C, Holmes T, Macleod H, Kinnear W, Oliver D, Leigh N, Ampong M-A (2006) Management of respiration in MND/ALS patients: an evidence based review [online]. http://www.mndassociation.org/life_with_mnd/getting_more_information/publications/publications_1.html. Accessed 27 Feb 2009
Miller RG, Rosenberg JA, Gelinas DF, Mitsumoto H, Newman D, Sufit R et al (2006) Practice parameter: the care of the patient with amyotrophic lateral sclerosis (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 52:1311
National Institute for Health and Clinical Excellence (2010) Motor neurone disease: the use of non-invasive ventilation in the management of motor neurone disease. Full guideline [online]. http://www.nice.org.uk/nicemedia/live/12106/47600/47600.pdf. Accessed 26 Mar 2010
Radunovic A, Annane D, Jewitt K, Mustfa N (2009) Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease. (Cochrane Review). In: The Cochrane Library, Issue 4, Wiley, Chichester. doi:10.1002/14651858.CD004427.pub2
Vesey S, Leslie P, Exley C (2008) A pilot study exploring the factors that influence the decision to have PEG feeding in patients with progressive conditions. Dysphagia 23:310–316
Martin NJ, Landau S, Janssen A, Lyall R, Higginson I, Burman R et al (2014) Psychological as well as illness factors influence acceptance of non-invasive ventilation (NIV) and gastrostomy in amyotrophic lateral sclerosis (ALS): a prospective population study. Amyotroph Lateral Scler Frontotemp Degen 15:376–387
Chio A, Calvo A, Moglia C, Gamna F, Mattei A, Mazzini L et al (2012) Non-invasive ventilation in amyotrophic lateral sclerosis: a 10 year population based study. J Neurol Neurosurg Psychiatry 83:377–381
Bradley WG, Anderson F, Gowda N, Miller RG, and the ALS CARE Study Group (2004) Changes in the management of ALS since the publication of the AAN ALS Practice Parameter 1999. Amyotroph Lateral Scler 5:240–244
Forbes RB, Colville S, Swingler RJ (2004) Frequency, timing and outcome of gastrostomy tubes for amyotrophic lateral sclerosis/motor neurone disease: a record linkage study from the Scottish Motor Neurone Disease Register. J Neurol 251:813–817
Lechtzin N, Wiener CM, Clawson L, Davidson MC, Anderson F, Gowda N et al (2004) Use of noninvasive ventilation in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler 5:9–15
McDonald ER, Hillel A, Wiedenfeld SA (1996) Evaluation of the psychological status of ventilatory-supported patients with ALS/MND. Palliat Med 10:35–41
Murphy PL, Albert SM, Weber CM, Del Bene ML, Rowland LP (2000) Impact of spirituality and religiousness on outcomes in patients with ALS. Neurology 55:1581–1584
Albert SM, Murphy PL, Del Bene ML, Rowland LP (1999) A prospective study of preferences and actual treatment choices in ALS. Neurology 53:278–283
Albert SM, Murphy PL, Del Bene M, Rowland LP, Mitsumoto H (2001) Incidence and predictors of PEG placement in ALS/MND. J Neurol Sci 191:115–119
Johnson J, Leigh PN, Shaw CE, Ellis C, Burman R, Al-Chalabi A (2012) Eating-derived pleasure in amyotrophic lateral sclerosis as a predictor of non-oral feeding. Amyotroph Lateral Scler 13:555–559
Young JM, Marshall CL, Anderson EJ (1994) Amyotrophic lateral sclerosis patients’ perspectives on use of mechanical ventilation. Health Soc Work 19:253–260
Goldstein LH, Atkins L, Landau S, Brown R, Leigh PN (2006) Predictors of psychological distress in carers of people with amyotrophic lateral sclerosis: a longitudinal study. Psychol Med 38:865–875
Van Rosendaal GMA, Verhoef MJ, Kinsella TD (1999) How are decisions made about the use of percutaneous endoscopic gastrostomy for long-term nutritional support? Am J Gastroenterol 94:3225–3228
Lemoignan J, Ells C (2010) Amyotrophic lateral sclerosis and assisted ventilation: how patients decide. Palliat Support Care 8:207–213
Hogden A, Greenfield D, Nugus P, Kiernan MC (2012) What influences patient decision-making in amyotrophic lateral sclerosis multidisciplinary care? A study of patient perspectives. Patient Pref Adherence 6:829–838
Foley G, Timonen V, Hardiman O (2014) Acceptance and decision making in amyotrophic lateral sclerosis from a life-course perspective. Qual Health Res 24:67–77
Todd V, Van Rosendaal G, Duregon K, Verhoef M (2005) Percutaneous endoscopic gastrostomy (PEG): the role and perspective of nurses. J Clin Nursing 14:187–194
Ruffell T, Martin N, Janssen A, Wijesekera L, Knights C, Burman R et al (2013) Healthcare professionals’ views on the provision of gastrostomy and noninvasive ventilation to Amyotrophic Lateral Sclerosis patients in England, Wales, and Northern Ireland. J Palliat Care 29:224–230
Moss AH, Oppenheimer EA, Casey P, Cazzolli PA, Roos RP, Stocking CB et al (1996) Patients with amyotrophic lateral sclerosis receiving long-term mechanical ventilation: advance care planning and outcomes. Chest 110:249–255
Radunovic A, Mitsumoto H, Leigh PN (2007) Clinical care of patients with amyotrophic lateral sclerosis. Lancet Neurol 6:913–925
Silverstein MD, Stocking CB, Antel JP, Beckwith J, Roos RP, Siegler M (1991) Amyotrophic lateral sclerosis and life-sustaining therapy: patients’ desires for information, participation in decision-making and life-sustaining therapy. Mayo Clin Proc 66:906–913
O’Brien MR (2004) Information seeking behaviour among people with motor neurone disease. Br J Nursing 13:964–968
Brotherton A, Abbott J (2009) Clinical decision making and the provision of information in PEG feeding: an exploration of patients and their carers’ perceptions. J Hum Nut Dietetics 22:302–309
Brotherton A, Abbott J, Hurley MA, Aggett PJ (2007) Home percutaneous endoscopic gastrostomy feeding: perceptions of patients, carers, nurses and dieticians. J Adv Nursing 59:388–397
Abhinav K, Stanton B, Johnston C, Hardstaff J, Orrell RW, Howard R et al (2007) Amyotrophic lateral sclerosis in south east England: a population based study The South East England register for amyotrophic lateral sclerosis (SEALS registry). Neuroepdiemiol 29:44–48
Braun V, Clarke V (2006) Using thematic analysis in psychology. Qual Res Psychol 3:77–101
King SJ, Duke MM, O’Connor BA (2009) Living with amyotrophic lateral sclerosis/motor neurone disease: decision-making about ‘ongoing change and adaptation’. J Clin Nursing 18:745–754
Simmons Z, Bremer BA, Robbins RA, Walsh SM, Fischer S (2000) Quality of life in ALS depends on factors other than strength and physical function. Neurology 55:388–392
Goldstein LH, Abrahams S (2013) Changes in cognition and behaviour in amyotrophic lateral sclerosis: nature of impairment and implications for assessment. Lancet Neurol 12:368–380
Olney RK, Murphy J, Forshew D, Garwood E, Miller BL, Langmore S et al (2005) The effects of executive and behavioral dysfunction on the course of ALS. Neurology 65:1774–1777
Abrahams S, Newton J, Niven E, Foley J, Bak T (2014) Screening for cognition and behaviour changes in ALS. Amyotroph Lateral Scler Frontotemporal Degener 15:9–14
Acknowledgments
This study was funded by the Motor Neurone Disease Association, UK. AA-C received support from the European Commission’s Health Seventh Framework Programme. AA-C and LHG receive salary support from the National Institute for Health Research (NIHR) Dementia Biomedical Research Unit at the South London and Maudsley NHS Foundation Trust and King’s College London. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. AJ has received research support from the Psychiatry Research Trust. NHM and AJ have received conference travel expenses from Brain. PNL has received other research support but not related to this study from the Medical Research Council, Motor Neurone Disease Association and the Wellcome Trust UK. LHG currently receives research support from the National Institute for Health Research (NIHR) UK.
Conflicts of interest
The authors have no conflict of interest to declare.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Greenaway, L.P., Martin, N.H., Lawrence, V. et al. Accepting or declining non-invasive ventilation or gastrostomy in amyotrophic lateral sclerosis: patients’ perspectives. J Neurol 262, 1002–1013 (2015). https://doi.org/10.1007/s00415-015-7665-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-015-7665-z